Sloan Kettering Institute scientists design CAR T cells to activate cancer pro-drugs at the disease site
Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.
